GenRocket vs iRemedy: Revenue, Funding & Team Size Compared
GenRocket generates $3M in revenue; iRemedy generates $3M. iRemedy and GenRocket are close to the same size by revenue. The table below compares GenRocket and iRemedy on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company | ||
|---|---|---|
| Revenue | $3M | $3M |
| Valuation | Not disclosed | $21M |
| Team size | 27 | 33 |
| Founded | 2012 | 2005 |
| HQ | Ojai, United States | Stuart, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
GenRocket at a glance
GenRocket generates $3M in revenue with 27 employees, headquartered in Ojai, United States.
- Revenue
- $3M
- Team size
- 27
- Founded
- 2012
GenRocket is a market leader in synthetic test data. The company works closely with IT services companies and enterprise customers to reduce cycle times and increase the quality of software development and testing caused by a lack of test…
iRemedy at a glance
iRemedy generates $3M in revenue with 33 employees, headquartered in Stuart, United States.
- Revenue
- $3M
- Valuation
- $21M
- Team size
- 33
- Founded
- 2005
Operator of a marketplace intended to streamline the buying process for patients and their providers. The company offers branded e-commerce storefronts that are customized for B2B and B2C buyers, providing users with a convenient and…
Other GenRocket alternatives
GenRocket competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
GenRocket vs iRemedy: frequently asked questions
Is GenRocket or iRemedy bigger?
iRemedy is the bigger company by revenue, at $3M against $3M for GenRocket.
How much revenue does GenRocket make?
GenRocket generates $3M in annual revenue with a team of 27.
How much revenue does iRemedy make?
iRemedy generates $3M in annual revenue with a team of 33.